Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-07-03-Speech-2-160"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2001-07-03"^^xsd:date2
dcterms:Is Part Of	lp_eu:Question Time (Commission)2
dcterms:Language	"es"^^xsd:language2
lpv:document identification number	"en.20010703.9.2-160"2
lpv:hasSubsequent	lp_eu:2001-07-03-Speech-2-1612
lpv:speaker	lp:Alonso José Puerta2
lpv:spokenAs	substitute; AFCO (1999-07-21--2002-01-14)3 unknown; Izquierda Unida (1999-07-20--2004-07-19)3 vice-president; Parliament's Bureau (1999-07-20--2002-01-14)3 member; Delegation for relations with Australia and New Zealand (1999-09-29--2002-01-14)3 member; Committee on Regional Policy, Transport and Tourism (1999-07-21--2002-01-14)3 member_of_the_bureau; EUL/NGL (1999-10-13--2004-07-19)3 vice-president; European Parliament (1999-07-20--2002-01-14)3
lpv:translated text	"Question No 31 by Ulla Margrethe Sandbæk (): Given the mounting evidence and public concern about the negative impact of WTO patent rules on poor peoples’ access to medicines, will the EU support and promote proposals from developing countries at the forthcoming TRIPs Councils and the WTO ministerial meeting in Qatar for WTO members to agree a review of public health and development implications of TRIPs and a moratorium on trade disputes with developing countries over TRIPs compliance until the review is complete, together with a revision of the TRIPs Agreement to allow developing countries the option of reducing the length and scope of patents on public health grounds?"@en1
lpv:unclassifiedMetadata	"President. –"1 "Subject: Poor peoples' access to medicines"1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph